BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38022516)

  • 1. Association of genes in hereditary metabolic diseases with diagnosis, prognosis, and treatment outcomes in gastric cancer.
    Li Y; Li X; Yang Y; Qiao X; Tao Q; Peng C; Han M; Dong K; Xu M; Wang D; Han G
    Front Immunol; 2023; 14():1289700. PubMed ID: 38022516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
    Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
    Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
    Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
    Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
    Hu B; Meng Y; Qu C; Wang BY; Xiu DR
    Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
    Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
    Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
    Liu ZY; Xin L
    Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
    Li X; Xiong F; Hu Z; Tao Q; Yang Y; Qiao X; Peng C; Jiang Y; Han M; Dong K; Hua Y; Zhang W; Xu M; Long W; Xiao Y; Wang D
    J Transl Med; 2024 Jan; 22(1):90. PubMed ID: 38254099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
    Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
    Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel adenosine signalling-based prognostic signature in gastric cancer and its association with cancer immune features and immunotherapy response.
    Yu Y; Wang Y; Xi D; Wang N; Gao L; Shi Q; Yu R; Li H; Xiang L; Maswikiti EP; Chen H
    Cell Biol Int; 2023 Sep; 47(9):1650-1664. PubMed ID: 37366248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Genomic Signature Reflecting Fibroblast Infiltration Into Gastric Cancer Is Associated With Prognosis and Treatment Outcomes of Immune Checkpoint Inhibitors.
    Lu Y; Li D; Cao Y; Ying L; Tao Q; Xiong F; Hu Z; Yang Y; Qiao X; Peng C; Zhu D; Wang D; Li X
    Front Cell Dev Biol; 2022; 10():862294. PubMed ID: 35557959
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
    Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
    Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis.
    Chen S; Huang M; Zhang L; Huang Q; Wang Y; Liang Y
    Comput Struct Biotechnol J; 2024 Dec; 23():369-383. PubMed ID: 38226313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer.
    Tang W; Li G; Lin Q; Zhu Z; Wang Z; Wang Z
    J Transl Med; 2023 Dec; 21(1):887. PubMed ID: 38062450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
    Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
    Front Immunol; 2022; 13():951214. PubMed ID: 35967313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.
    Xiang K; Zhang M; Yang B; Liu X; Wang Y; Liu H; Song Y; Yuan Y; Zhang L; Wen T; Zhang GW
    Int Immunopharmacol; 2024 Jun; 134():112224. PubMed ID: 38723370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
    Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
    Front Immunol; 2022; 13():977338. PubMed ID: 36159818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
    Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.